St Andrews Research Repository

St Andrews University Home
View Item 
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  • Register / Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Forecasting clinical dose-response from pre-clinical studies in tuberculosis research - translational predictions with rifampicin

Thumbnail
View/Open
Wicha_et_al_2018_Clinical_Pharmacology_26_Therapeutics_CC.pdf (638.0Kb)
Date
19/06/2018
Author
Wicha, Sebastian G.
Clewe, Oskar
Svensson, Robin J.
Gillespie, Stephen H.
Hu, Yanmin
Coates, Anthony R.m.
Simonsson, Ulrika S.h.
Funder
European Commission
Grant ID
Keywords
Forward translational
Tuberculosis
Rifampicin
RA0421 Public health. Hygiene. Preventive Medicine
RM Therapeutics. Pharmacology
NDAS
SDG 3 - Good Health and Well-being
Metadata
Show full item record
Abstract
A crucial step for accelerating tuberculosis drug development is bridging the gap between pre‐clinical and clinical trials. In this study, we developed a pre‐clinical model‐informed translational approach to predict drug effects across pre‐clinical systems and early clinical trials using the in vitro‐based Multistate Tuberculosis Pharmacometric (MTP) model using rifampicin as an example. The MTP model predicted rifampicin biomarker response observed in (i) a hollow‐fiber infection model, (ii) a murine study to determine PK/PD indices, and (iii) several clinical phase IIa early bactericidal activity (EBA) studies. In addition, we predicted rifampicin biomarker response at high doses of up to 50 mg/kg, leading to an increased median EBA0‐2 days (90% prediction interval) of 0.513 log CFU/mL/day (0.310; 0.701) compared to the standard dose of 10 mg/kg of 0.181 log/CFU/mL/day (0.076; 0.483). These results suggest that the translational approach could assist in the selection of drugs and doses in early‐phase clinical tuberculosis trials.
Citation
Wicha , S G , Clewe , O , Svensson , R J , Gillespie , S H , Hu , Y , Coates , A R M & Simonsson , U S H 2018 , ' Forecasting clinical dose-response from pre-clinical studies in tuberculosis research - translational predictions with rifampicin ' , Clinical Pharmacology & Therapeutics , vol. Early View . https://doi.org/10.1002/cpt.1102
Publication
Clinical Pharmacology & Therapeutics
Status
Peer reviewed
DOI
https://doi.org/10.1002/cpt.1102
ISSN
0009-9236
Type
Journal article
Rights
© 2018 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Description
This work was funded by: The Swedish Research Council (grant number 521‐2011‐3442) and the Innovative Medicines Initiative Joint Undertaking (www.imi.europe.eu) under grant agreement 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007‐2013) and EFPIA companies' in kind contribution.
Collections
  • University of St Andrews Research
URI
http://hdl.handle.net/10023/14604

Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

Advanced Search

Browse

All of RepositoryCommunities & CollectionsBy Issue DateNamesTitlesSubjectsClassificationTypeFunderThis CollectionBy Issue DateNamesTitlesSubjectsClassificationTypeFunder

My Account

Login

Open Access

To find out how you can benefit from open access to research, see our library web pages and Open Access blog. For open access help contact: openaccess@st-andrews.ac.uk.

Accessibility

Read our Accessibility statement.

How to submit research papers

The full text of research papers can be submitted to the repository via Pure, the University's research information system. For help see our guide: How to deposit in Pure.

Electronic thesis deposit

Help with deposit.

Repository help

For repository help contact: Digital-Repository@st-andrews.ac.uk.

Give Feedback

Cookie policy

This site may use cookies. Please see Terms and Conditions.

Usage statistics

COUNTER-compliant statistics on downloads from the repository are available from the IRUS-UK Service. Contact us for information.

© University of St Andrews Library

University of St Andrews is a charity registered in Scotland, No SC013532.

  • Facebook
  • Twitter